NASDAQ:UNCY
Unicycive Therapeutics, Inc. Stock News
$1.04
+0.0100 (+0.97%)
At Close: May 17, 2024
Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023
07:03am, Wednesday, 29'th Nov 2023
LOS ALTOS, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies fo
Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update
04:15pm, Tuesday, 14'th Nov 2023
Reached Alignment with the FDA on the Data Package Requirements to File NDA for oxylanthanum carbonate (OLC) OLC Pivotal Clinical Trial Expected to Initiate Before Year End LOS ALTOS, Calif., Nov. 14,
Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)
07:03am, Monday, 23'rd Oct 2023
- Pivotal clinical trial expected to initiate before year end - LOS ALTOS, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology compan
The 7 Most Undervalued Penny Stocks to Buy in October 2023
07:20am, Friday, 06'th Oct 2023
Investing in undervalued penny stocks is always going to be about the same few things. Most investors are attempting to find cheap, short-term plays with reasonable catalysts in their favor.
Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD
07:03am, Wednesday, 06'th Sep 2023
Appointment adds decades of drug development experience from a seasoned executive Appointment adds decades of drug development experience from a seasoned executive
Why Is Unicycive Therapeutics (UNCY) Down 24% Today?
09:28am, Friday, 30'th Jun 2023
Unicycive Therapeutics (NASDAQ: UNCY ) stock is falling on Friday after the medical company provided investors with an update from regulators. According to the clinical-stage biotechnology company, th
LOS ALTOS, Calif., June 16, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, announc
Analyzing Penny Stocks After a Market Crash, 3 Tips
06:00am, Monday, 13'th Mar 2023
Use these tips for analyzing penny stocks after a market crash The post Analyzing Penny Stocks After a Market Crash, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
How to Identify Promising Penny Stocks: 3 Tips
11:00am, Saturday, 11'th Mar 2023
Use these tips for identifying promising penny stocks The post How to Identify Promising Penny Stocks: 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
How to Future Proof Your Penny Stocks Investing Strategy
06:00am, Friday, 10'th Mar 2023
Use these tips for future proofing your penny stocks strategy The post How to Future Proof Your Penny Stocks Investing Strategy appeared first on Penny Stocks to Buy, Picks, News and Information | P
Penny Stocks Investing: The Pros and Cons of Day Trading
06:00am, Wednesday, 08'th Mar 2023
What you need to know about day trading penny stocks The post Penny Stocks Investing: The Pros and Cons of Day Trading appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.
Penny Stocks Trading: Tips for Market Uncertainty
06:00am, Tuesday, 07'th Mar 2023
Use these tips for trading penny stocks during market uncertainty The post Penny Stocks Trading: Tips for Market Uncertainty appeared first on Penny Stocks to Buy, Picks, News and Information | Penn
Unicycive to Participate in Upcoming Investor Conferences
07:00am, Monday, 28'th Nov 2022
Highlights Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of Mitochondrial Dysfunction Highlights Late-Stage Program in Hyperphosphatemia and Early-Stage Program to
Unicycive Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
07:00am, Tuesday, 06'th Sep 2022
Presentation to Highlight Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of Mitochondrial Dysfunction Presentation to Highlight Late-Stage Program in Hyperphosphate